Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke

ClinicalTrials.gov ID: NCT05421533

Public ClinicalTrials.gov record NCT05421533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 7:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Global Prospective observationAl Study of Real-worlD managemEnt of patieNts With atrIal fibrillAtion at High Risk of Stroke (GARDENIA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The GARDENIA registry will collect real-world clinical data on the anticoagulant strategies in patients with AF at elevated risk of stroke but also elevated risk of bleeding.

Study identification

NCT ID
NCT05421533
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Anthos Therapeutics, Inc.
Industry
Enrollment
705 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2022 (Actual)
Primary completion
Sep 30, 2024 (Actual)
Completion
Sep 30, 2024 (Actual)
Last update posted
Dec 3, 2024

2022 – 2024

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Anthos Investigate Site Fullerton California 92831 —
Anthos Investigate Site Boca Raton Florida 33486 —
Anthos Investigative Site Homestead Florida 33032 —
Anthos Investigate Site Atlanta Georgia 30342 —
Anthos Investigate Site Marietta Georgia 30062 —
Anthos Investigative Site Lanham Maryland 20706 —
Anthos Investigate Site Detroit Michigan 48202 —
Anthos Investigate Site Cary North Carolina 27518 —
Anthos Investigate Site Tomball Texas 77375 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05421533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2024 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05421533 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →